A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)

NCT06245941 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
21
Enrollment
INDUSTRY
Sponsor class

Stopped Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.

Conditions

Interventions

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.